reimbursers

Personalized medicine: GenomOncology on the “silliness” of reimbursers

Personalized medicine is here. But it’s up to insurance carriers to catch up with technology that’s hurtling forward faster and faster, or so says Manuel Glynias, CEO of Cleveland-based GenomOncology,  His company is in the business of solving how doctors can use genomic data to treat cancer, the first major frontier in the application of personalized medicine. It’s difficult to parse the […]